These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 19591609)
1. Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study. Young B; Buchacz K; Moorman A; Wood KC; Brooks JT; AIDS Patient Care STDS; 2009 Aug; 23(8):589-92. PubMed ID: 19591609 [TBL] [Abstract][Full Text] [Related]
2. Progressive renal tubular dysfunction associated with long-term use of tenofovir DF. Kinai E; Hanabusa H AIDS Res Hum Retroviruses; 2009 Apr; 25(4):387-94. PubMed ID: 19361280 [TBL] [Abstract][Full Text] [Related]
3. Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215). De Beaudrap P; Diallo MB; Landman R; Guèye NF; Ndiaye I; Diouf A; Kane CT; Etard JF; Girard PM; Sow PS; Delaporte E; AIDS Res Hum Retroviruses; 2010 Nov; 26(11):1221-7. PubMed ID: 20854202 [TBL] [Abstract][Full Text] [Related]
4. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa. Kamkuemah M; Kaplan R; Bekker LG; Little F; Myer L Trop Med Int Health; 2015 Apr; 20(4):518-26. PubMed ID: 25442109 [TBL] [Abstract][Full Text] [Related]
5. Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians. Agbaji OO; Agaba PA; Idoko JA; Taiwo B; Murphy R; Kanki P; Ekong E West Afr J Med; 2011; 30(3):164-8. PubMed ID: 22120479 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and factors associated with renal dysfunction among HIV-infected patients. Crum-Cianflone N; Ganesan A; Teneza-Mora N; Riddle M; Medina S; Barahona I; Brodine S AIDS Patient Care STDS; 2010 Jun; 24(6):353-60. PubMed ID: 20515419 [TBL] [Abstract][Full Text] [Related]
7. Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. Horberg M; Tang B; Towner W; Silverberg M; Bersoff-Matcha S; Hurley L; Chang J; Blank J; Quesenberry C; Klein D J Acquir Immune Defic Syndr; 2010 Jan; 53(1):62-9. PubMed ID: 19838127 [TBL] [Abstract][Full Text] [Related]
8. Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico. Andrade-Fuentes K; Mata-Marín JA; López-De León JI; Manjarrez-Téllez B; Ramírez JL; Gaytan-Martínez J AIDS Patient Care STDS; 2015 Apr; 29(4):181-5. PubMed ID: 25101526 [TBL] [Abstract][Full Text] [Related]
9. Renal function with use of a tenofovir-containing initial antiretroviral regimen. Gallant JE; Moore RD AIDS; 2009 Sep; 23(15):1971-5. PubMed ID: 19696652 [TBL] [Abstract][Full Text] [Related]
10. Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up. Nishijima T; Kawasaki Y; Tanaka N; Mizushima D; Aoki T; Watanabe K; Kinai E; Honda H; Yazaki H; Tanuma J; Tsukada K; Teruya K; Kikuchi Y; Gatanaga H; Oka S AIDS; 2014 Aug; 28(13):1903-10. PubMed ID: 25259702 [TBL] [Abstract][Full Text] [Related]
11. The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients. Wikman P; Safont P; Del Palacio M; Moreno A; Moreno S; Casado JL Nephrol Dial Transplant; 2013 Aug; 28(8):2073-81. PubMed ID: 23739150 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of renal adverse effects of combination anti-retroviral therapy including tenofovir in HIV-infected patients. Tanaka H; Arai M; Tomoda Y; Wada T; Yago K; Satoh M J Pharm Pharm Sci; 2013; 16(3):405-13. PubMed ID: 24021289 [TBL] [Abstract][Full Text] [Related]
13. Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia. Mulenga L; Musonda P; Mwango A; Vinikoor MJ; Davies MA; Mweemba A; Calmy A; Stringer JS; Keiser O; Chi BH; Wandeler G; Clin Infect Dis; 2014 May; 58(10):1473-80. PubMed ID: 24585558 [TBL] [Abstract][Full Text] [Related]
14. Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy. Goicoechea M; Liu S; Best B; Sun S; Jain S; Kemper C; Witt M; Diamond C; Haubrich R; Louie S; J Infect Dis; 2008 Jan; 197(1):102-8. PubMed ID: 18171292 [TBL] [Abstract][Full Text] [Related]
15. High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy. Bonjoch A; Echeverría P; Perez-Alvarez N; Puig J; Estany C; Clotet B; Negredo E Antiviral Res; 2012 Oct; 96(1):65-9. PubMed ID: 22892171 [TBL] [Abstract][Full Text] [Related]
16. Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF. Hodder SL; Mounzer K; Dejesus E; Ebrahimi R; Grimm K; Esker S; Ecker J; Farajallah A; Flaherty JF; AIDS Patient Care STDS; 2010 Feb; 24(2):87-96. PubMed ID: 20156091 [TBL] [Abstract][Full Text] [Related]
17. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV]. Bayonne Kombo ES; Gathse A Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355 [No Abstract] [Full Text] [Related]
18. Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. Labarga P; Barreiro P; Martin-Carbonero L; Rodriguez-Novoa S; Solera C; Medrano J; Rivas P; Albalater M; Blanco F; Moreno V; Vispo E; Soriano V AIDS; 2009 Mar; 23(6):689-96. PubMed ID: 19262355 [TBL] [Abstract][Full Text] [Related]
19. Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients. Manfredi R; Calza L AIDS Patient Care STDS; 2008 Apr; 22(4):279-90. PubMed ID: 18290748 [TBL] [Abstract][Full Text] [Related]
20. Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study. Cao Y; Han Y; Xie J; Cui Q; Zhang L; Li Y; Li Y; Song X; Zhu T; Li T BMC Infect Dis; 2013 Jul; 13():301. PubMed ID: 23815472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]